08 Apr 2024 --- A new clinical trial links keto diets to “dramatic improvements” in metabolic function and psychiatric symptoms in patients diagnosed with either bipolar disorder or schizophrenia who were also overweight or met criteria for metabolic abnormalities, such as insulin resistance or impaired glucose tolerance. According to the researchers, the dual improvements found in the trial are rare in mental health care, as treatments often lead to significant comorbidities, such as weight gain, obesity, dyslipidemia (imbalance of lipids, such as cholesterol) and cardiometabolic disease.
